Adaptimmune Therapeutics plc (ADAP): Price and Financial Metrics

Adaptimmune Therapeutics plc (ADAP): $0.80

0.07 (+10.23%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

A

Add ADAP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#7 of 328

in industry

ADAP Price/Volume Stats

Current price $0.80 52-week high $2.05
Prev. close $0.73 52-week low $0.42
Day low $0.73 Volume 1,118,800
Day high $0.82 Avg. volume 1,661,503
50-day MA $0.97 Dividend yield N/A
200-day MA $1.13 Market Cap 204.54M

ADAP Stock Price Chart Interactive Chart >


Adaptimmune Therapeutics plc (ADAP) Company Bio


Adaptimmune Therapeutics plc is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. The company was founded in 2014 and is based in Abingdon, the United Kingdom.


ADAP Latest News Stream


Event/Time News Detail
Loading, please wait...

ADAP Latest Social Stream


Loading social stream, please wait...

View Full ADAP Social Stream

ADAP Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching ADAP

Here are a few links from around the web to help you further your research on Adaptimmune Therapeutics PLC's stock as an investment opportunity:

Adaptimmune Therapeutics PLC (ADAP) Stock Price | Nasdaq
Adaptimmune Therapeutics PLC (ADAP) Stock Quote, History and News - Yahoo Finance
Adaptimmune Therapeutics PLC (ADAP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!